HK inno.N Pushes Point-of-Care Testing Into the Chronic-Care Workflow
Chronic disease management is pulling diagnostics into same-visit care, creating a recurring workflow market for point-of-care platforms.
Updated
What is this trend?
Point-of-care testing is moving into chronic-care visits, letting clinics run HbA1c, lipid, and CRP tests during the same appointment and tightening follow-up workflows.
- Same-visit testing is becoming the new chronic-care default.
- HbA1c, lipid, and CRP assays are moving into hospitals and neighborhood clinics.
- Distribution networks matter as much as the test platform itself.
- Chronic disease is turning diagnostics into repeat-use infrastructure.
- Winning models pair devices with consumables, software, and service revenue.
What’s the latest?
HK inno.N’s entry into point-of-care testing with Roche’s cobas click platform is the latest sign that chronic-care demand is moving testing into same-visit workflows: HbA1c, lipid, and CRP assays are
How it developed
- Reimbursement, real-world evidence, and workflow impact reshape device competition
- Connected Monitoring Is Becoming a Reimbursement-Driven Platform Market
Go deeper
Curated long-form picks on this trend — podcasts, videos, and analysis, by vantage.
